InvestSMART

Atomo Diagnostics Limited (ASX: AT1) - Announcements

- Current share price for AT1 : $0.017

ASX company news and announcements for Atomo Diagnostics Limited (AT1) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Atomo Diagnostics Limited (AT1) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Atomo Diagnostics Limited (AT1), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Atomo Diagnostics Limited (AT1)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$15 Atomo to present at Canaccord US Growth Conference 12 Aug 2020 11:03AM $0.380 $0.017 fallen by 95.53%
$15 Canaccord US Growth Conference Presentation 11 Aug 2020 6:52PM $0.375 $0.017 fallen by 95.47%
$15 Atomo receives TGA approval for COVID19 antibody test 10 Aug 2020 10:37AM $0.345 $0.017 fallen by 95.07%
$15 Pause in Trading 10 Aug 2020 10:00AM $0.340 $0.017 fallen by 95%
$15 Change of Auditor 3 Aug 2020 10:30AM $0.360 $0.017 fallen by 95.28%
$15 Atomo to present at the NWR Small Cap Conference 31 Jul 2020 2:59PM $0.368 $0.017 fallen by 95.37%
$15 Investor Presentation 29 July 2020 29 Jul 2020 8:21AM $0.395 $0.017 fallen by 95.70%
$15 Atomo & Access Bio enter North American COVID-19 partnership 28 Jul 2020 1:30PM $0.365 $0.017 fallen by 95.34%
$15 Atomo to present at IRD Invest Virtual Investor Conference 27 Jul 2020 8:49AM $0.375 $0.017 fallen by 95.47%
$15 Quarterly Activity Report & Appendix 4C - 30 June 2020 22 Jul 2020 9:58AM $0.390 $0.017 fallen by 95.64%
$15 Change in substantial holding 15 Jun 2020 10:14AM $0.305 $0.017 fallen by 94.43%
$15 S&P DJI Announces June 2020 Quarterly Rebalance 12 Jun 2020 8:16AM $0.305 $0.017 fallen by 94.43%
$15 Amended Share Trading Policy 9 Jun 2020 2:58PM $0.320 $0.017 fallen by 94.69%
$15 Atomo and NG Biotech expand COVID-19 partnership 4 Jun 2020 6:36PM $0.315 $0.017 fallen by 94.60%
$15 Pause in Trading 4 Jun 2020 9:58AM $0.315 $0.017 fallen by 94.60%
$15 Change in substantial holding 2 Jun 2020 4:18PM $0.315 $0.017 fallen by 94.60%
$15 Change in substantial holding 8 May 2020 5:21PM $0.430 $0.017 fallen by 96.05%
$15 Atomo receives additional order for COVID19 test devices 7 May 2020 11:01AM $0.445 $0.017 fallen by 96.18%
$15 Pause in Trading 7 May 2020 9:59AM $0.445 $0.017 fallen by 96.18%
$15 Change in substantial holding 1 May 2020 2:22PM $0.453 $0.017 fallen by 96.24%
$15 Atomo to present at Virtual Health Conference 30 Apr 2020 10:03AM $0.490 $0.017 fallen by 96.53%
$15 Notice of Initial Substantial Holder 23 Apr 2020 5:17PM $0.415 $0.017 fallen by 95.90%
$15 Becoming a substantial holder 20 Apr 2020 12:39PM $0.550 $0.017 fallen by 96.91%
$15 Notice of Initial Substantial Holder 20 Apr 2020 8:30AM $0.520 $0.017 fallen by 96.73%
$15 Initial Director's Interest Notice - P Kasian 20 Apr 2020 8:26AM $0.520 $0.017 fallen by 96.73%

351 - 375 of 398 results

Page 15 of 16

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.